Data compiled by Redley Lamar · ChainSifter Intelligence
7Suppliers
8Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Vivos Therapeutics, Inc. (VVOS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
19Total relationships
5Distinct source URLs
13High confidence
0.801Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Vivos Therapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
V-CO-INVESTORS-3-LLC
V-CO-INVESTORS-3-LLC
92%
Vivos Therapeutics, Inc. entered into an unsecured convertible promissory note in favor of V-Co Investors 3 LLC
V-CO-INVESTORS-4-LLC
V-CO-INVESTORS-4-LLC
92%
V-Co Investors 4 LLC funded an initial $500,000 to the Company under the V-Co 4 Note
NEW-SENECA-PARTNERS-INC
NEW-SENECA-PARTNERS-INC
90%
V-Co is an affiliate of New Seneca Partners Inc., an existing private equity investor in, and advisor to, the Company
V-CO-2
V-CO-2
90%
Pursuant to the June 2025 PIPE SPA, the Company sold to V-Co 2 in a private placement offering
V-CO-INVESTORS-LLC
V-CO-INVESTORS-LLC
90%
Pursuant to the June 2024 SPA, we sold to V-CO in a private placement offering
H-C-WAINWRIGHT-CO-LLC
H-C-WAINWRIGHT-CO-LLC
80%
H.C. Wainwright & Co., LLC (" HCW "), pursuant an engagement agreement with us, dated May 2, 2024 and amended on August 2, 2024 acted as the exclusive placement agent
SENECA
SENECA
80%
V-CO is an affiliate of Seneca, a leading independent private equity firm
Vivos Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
V-CO-INVESTORS-3-LLC
V-CO-INVESTORS-3-LLC
90%
Pursuant to the PIPE SPA, the Company sold to V-Co 3 in a private placement offering
NEW-SENECA-PARTNERS-INC
NEW-SENECA-PARTNERS-INC
85%
V-Co 3 is an affiliate of New Seneca Partners Inc., a Michigan corporation
ADVANCED-FACIALDONTICS-LLC
ADVANCED-FACIALDONTICS-LLC
62%
ional profit center for both Vivos and providers. ○ Vivos Vida™ is our proprietary FDA-cleared appliance (unspecified classification) that incorporates our patented Unilateral Biteblock technology fo…
AIRWAY-INTELLIGENCE-CENTER-LLC
AIRWAY-INTELLIGENCE-CENTER-LLC
62%
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo…
M-A-GROUP
M-A-GROUP
62%
. Under our new model, we generate revenue through (i) sleep testing services and (ii) via our SAMC facilities, patient customized OSA treatments (which can include, but are not limited to, treatment…
MISLEEP-SOLUTION-LLC
MISLEEP-SOLUTION-LLC
62%
lly generate collections in excess of $500,000 per month, net of adjustments, with contribution margins above 50%. In addition to current Vivos diagnostic and treatment options, we expect to be able …
MYCARDIO-LLC
MYCARDIO-LLC
62%
. Under our new model, we generate revenue through (i) sleep testing services and (ii) via our SAMC facilities, patient customized OSA treatments (which can include, but are not limited to, treatment…
VIVOS-AIRWAY-ALLIANCE-LLC
VIVOS-AIRWAY-ALLIANCE-LLC
62%
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo…
Vivos Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
VVOS-DEBT
Debt stack $8.1M
90%
Market cache reports total debt of $8.1M.
VVOS-DEBT-13470
Warrants outstanding: 16000
90%
xbrl warrant detail from xbrl 2025-12-31.
VVOS-DEBT-13471
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
Vivos Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Vivos Therapeutics, Inc..
Vivos Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
VVOS-OWNER-ARMISTICE-CAPITAL-LLC
ARMISTICE CAPITAL, LLC
90%
13F overlay lists ARMISTICE CAPITAL, LLC as top holder; 25 tracked holders.
Vivos Therapeutics, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
